Jones Christy 4

What Happened Jones Christy, a director of Beta Bionics, sold 1,406 shares on June 24, 2026. The transaction was reported as a sale at $15.00 per share for a total of $21,090. The filing identifies the sale code S (sale — open market or private sale).

Key Details

• Transaction date: 2026-06-24; Filing date (Form 4): 2026-06-25.
• Price and amount: 1,406 shares sold at $15.00 per share; total proceeds $21,090.
• Reported as: S (open market or private sale).
• Footnote: The shares were sold pursuant to a Rule 10b5-1 plan adopted February 19, 2026 (pre-scheduled trading plan).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Timeliness: Filing was submitted the next day (no late-filing flag indicated).

Context Sales executed under Rule 10b5-1 plans are typically pre-scheduled and are not by themselves definitive signals of an insider’s current view of the company. For retail investors, purchases tend to carry more weight as potential bullish signals; routine or pre-planned sales like this are common for liquidity or diversification purposes.